Cell News and Research

RSS

Direct primary care amendment may offer affordable health care options for Americans

The U.S. Senate today made an important step that could expand health care coverage to more Americans while simultaneously reducing costs. The Manager's Amendment, introduced by Senator Harry Reid (D-Nev.) this morning, includes a provision that would allow flat-fee direct primary care practices, in which patients pay a flat fee for primary and preventive care, to compete in the proposed insurance exchange. This will provide Americans more affordable health care options beyond traditional insurance.

21 Dec 2009

Researchers determine structures of two enzymes that customize histones

Researchers at Emory University School of Medicine have determined the structures of two enzymes that customize histones, the spool-like proteins around which DNA coils inside the cell.

20 Dec 2009

Malaria nasal vaccine, antimicrobial peptide against MRSA, and safer method to prolong orange juice shelf life

An experiemental nasally administered malaria vaccine prevented parasite transmission from infected mice to mosquitoes and could play an important role in the fight against human malaria. The researchers from Japan report their findings in the December 2009 issue of the journal Infection and Immunity.

19 Dec 2009

Research lays hope for developing drugs that can control apoptosis

Walter and Eliza Hall Institute scientists have identified a key step in the biological process of programmed cell death, also called apoptosis.

19 Dec 2009

Charles Sherr awarded distinction of AAAS Fellow

Charles Sherr, M.D., Ph.D., co-chair of Genetics and Tumor Cell Biology at St. Jude Children's Research Hospital and a Howard Hughes Medical Institute Investigator, has been awarded the distinction of American Association for the Advancement of Science (AAAS) Fellow. AAAS is the world's largest general scientific society.

19 Dec 2009

Distinguished Young Scholars Program completed by W. M. Keck Foundation

The W. M. Keck Foundation, a leading supporter of pioneering medical research, science and engineering, today announced the successful completion of its Distinguished Young Scholars Program, a groundbreaking initiative created to give the nation's most promising young scientists the resources they need to pursue potentially breakthrough research projects in biomedical research.

19 Dec 2009

Majority of young adults support health reform legislation, says survey

An overwhelming majority-88 percent-of young adults across the political spectrum think it is important for Congress and the President to pass health reform legislation that would assure affordable health insurance for all and improve health care, according to a Commonwealth Fund survey released today.

19 Dec 2009

Annual diabetes Consumer Guide to be published in the January 2010 issue by Diabetes Forecast

When shopping for a new cell phone or even a car, there are dozens of features to explore and choices to make. The same is true of shopping for medical products that will help manage a chronic disease.

19 Dec 2009

IRB approves Neuralstem's Phase I trial to treat ALS with spinal cord stem cells

Neuralstem, Inc. today announced that its Phase I trial to treat Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's disease) with its spinal cord stem cells has been approved by the Institutional Review Board (IRB) at Emory University in Atlanta, GA.

19 Dec 2009

Possible link between presence of breast cancer genes and infertility discovered

A New York Medical College physician who specializes in restoring or preserving fertility in female cancer patients has discovered a possible link between the presence of breast cancer genes and infertility.

19 Dec 2009

Understanding the differences between skull bone and bones in limbs could prevent osteoporosis

Scientists at Queen Mary, University of London have uncovered fundamental differences between the bone which makes up the skull and the bones in our limbs, which they believe could hold the key to tackling bone weakness and fractures.

19 Dec 2009

John Theurer Cancer Center presents over 20 research updates and trial results at the 2009 ASH meeting

Doctors and researchers from the John Theurer Cancer Center at Hackensack University Medical Center recently presented research updates and clinical trial results of more than 20 innovative studies at the American Society of Hematology (ASH) annual meeting from December 5-8, 2009.

18 Dec 2009

GSK receives European CHMP positive opinion for Revolade

Ligand Pharmaceuticals Incorporated today announced that its partner GlaxoSmithKline has received a positive opinion for Revolade® (eltrombopag/Promacta®) from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) for the oral treatment of thrombocytopenia (reduced platelet count) in adults with the blood disorder chronic immune (idiopathic) thrombocytopenic purpura (ITP).

18 Dec 2009

Tackle Cancer Foundation calls attention to REVLIMID for myeloma patients

The TACKLE CANCER FOUNDATION wants to call attention to important news for patients with the blood cancer multiple myeloma. A new study shows patients benefit from daily medical treatments to keep their cancer in check after they have had a stem cell (bone marrow) transplant. The current standard of care is to give patients the transplant and then hold off on additional treatment until they relapse. The new study shows continuous treatment with the oral drug REVLIMID following the transplant significantly prolongs remission, increasing time to disease progression.

18 Dec 2009

PolyMedix completes first two segments of its PMX-30063 antibiotic drug candidate Phase 1B study

PolyMedix, Inc., an emerging biotechnology company developing acute care products for infectious diseases and acute cardiovascular disorders, has successfully completed the first two segments of a Phase 1B clinical safety study with its novel antibiotic drug candidate PMX-30063.

18 Dec 2009

Initial data from REVLIMID Phase III trial in multiple myeloma patients announced

Celgene Corporation today announced the National Cancer Institute (NCI), a part of the National Institutes of Health, reported initial data from a Phase III, randomized, double-blind, multi-center clinical study led by the Cancer and Leukemia Group B (CALGB).

18 Dec 2009

European CHMP announces positive opinion for Amgen's Prolia marketing authorization

Amgen Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has announced a positive opinion for the marketing authorization of Prolia((TM)) (denosumab) for the treatment of osteoporosis in postmenopausal women at increased risk of fractures, and for the treatment of bone loss associated with hormone ablation in men with prostate cancer at increased risk of fractures.

18 Dec 2009

Cell News and Research

Direct primary care amendment may offer affordable health care options for Americans

Researchers determine structures of two enzymes that customize histones

Malaria nasal vaccine, antimicrobial peptide against MRSA, and safer method to prolong orange juice shelf life

Research lays hope for developing drugs that can control apoptosis

Charles Sherr awarded distinction of AAAS Fellow

Distinguished Young Scholars Program completed by W. M. Keck Foundation

Majority of young adults support health reform legislation, says survey

Annual diabetes Consumer Guide to be published in the January 2010 issue by Diabetes Forecast

IRB approves Neuralstem's Phase I trial to treat ALS with spinal cord stem cells

Possible link between presence of breast cancer genes and infertility discovered

Understanding the differences between skull bone and bones in limbs could prevent osteoporosis

John Theurer Cancer Center presents over 20 research updates and trial results at the 2009 ASH meeting

GSK receives European CHMP positive opinion for Revolade

Tackle Cancer Foundation calls attention to REVLIMID for myeloma patients

PolyMedix completes first two segments of its PMX-30063 antibiotic drug candidate Phase 1B study

Initial data from REVLIMID Phase III trial in multiple myeloma patients announced

European CHMP announces positive opinion for Amgen's Prolia marketing authorization

Rosetta Genomics announces third-quarter 2009 financial results

New stem cell based technology may eliminate brain cancer

UAB professors honored for scientific contributions and outstanding mentorship

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest Life Science News